Fig. 2From: Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative dataRelationship between model 6 and PI-RADS v2. Tendency of model 6 in pace with PI-RADS v2 and the distributions of PCa among PI-RADS v2 scoresBack to article page